ATE390930T1 - Oberflächenschutz von frei liegenden biologischen geweben - Google Patents

Oberflächenschutz von frei liegenden biologischen geweben

Info

Publication number
ATE390930T1
ATE390930T1 AT04809189T AT04809189T ATE390930T1 AT E390930 T1 ATE390930 T1 AT E390930T1 AT 04809189 T AT04809189 T AT 04809189T AT 04809189 T AT04809189 T AT 04809189T AT E390930 T1 ATE390930 T1 AT E390930T1
Authority
AT
Austria
Prior art keywords
surface protection
biological tissues
exposed biological
relates
exposed
Prior art date
Application number
AT04809189T
Other languages
English (en)
Inventor
Stig Bengmark
Kare Larsson
Bjoern Lindman
Roland Andersson
Original Assignee
Bioactive Polymers Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0303588A external-priority patent/SE0303588D0/xx
Application filed by Bioactive Polymers Ab filed Critical Bioactive Polymers Ab
Application granted granted Critical
Publication of ATE390930T1 publication Critical patent/ATE390930T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT04809189T 2003-12-30 2004-12-23 Oberflächenschutz von frei liegenden biologischen geweben ATE390930T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303588A SE0303588D0 (sv) 2003-12-30 2003-12-30 Surface protection of exposed biological tissues
US60613004P 2004-09-01 2004-09-01

Publications (1)

Publication Number Publication Date
ATE390930T1 true ATE390930T1 (de) 2008-04-15

Family

ID=39273394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04809189T ATE390930T1 (de) 2003-12-30 2004-12-23 Oberflächenschutz von frei liegenden biologischen geweben

Country Status (10)

Country Link
US (2) US20080019955A1 (de)
EP (1) EP1701733B1 (de)
JP (1) JP5015604B2 (de)
CN (1) CN1917896B (de)
AT (1) ATE390930T1 (de)
CA (1) CA2550872C (de)
DE (1) DE602004012894T2 (de)
ES (1) ES2305897T3 (de)
PL (1) PL1701733T3 (de)
WO (1) WO2005063278A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2380605A1 (de) * 2010-04-19 2011-10-26 InnoRa Gmbh Verbesserte Formulierungen für wirkstoffbeschichtete medizinische Vorrichtungen
JP6224069B2 (ja) 2012-03-23 2017-11-01 アミクローブ，インコーポレイテッド 組織適合特性を有する抗菌剤の組成物および使用
CN106039393A (zh) * 2016-06-16 2016-10-26 湖州科达化工燃料有限公司 一种抗感染的皮肤用粘合剂
WO2018187617A1 (en) 2017-04-06 2018-10-11 Amicrobe, Inc. Compositions and uses of locally applied antimicrobials with enhanced performance and safety
AU2020292274B2 (en) 2019-06-13 2024-05-23 Hollister Incorporated Reusable urinary catheter products
CA3140908A1 (en) 2019-06-25 2020-12-30 Hollister Incorporated Reusable urinary catheter products
CN118161668B (zh) * 2024-05-11 2024-08-06 健诺维(成都)生物科技有限公司 一种温度敏感性羊膜凝胶材料及制备方法及应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3664939A (en) * 1970-04-22 1972-05-23 Univ California ISOELECTRIC FOCUSING AND FRACTIONATION AMPHOLYTES IN THERMALLY ENGENDERED pH GRADIENTS
SE361829B (de) * 1972-05-16 1973-11-19 Lkb Produkter Ab
US3901780A (en) * 1974-07-10 1975-08-26 Hoffmann La Roche Isoelectric focusing techniques and devices
US4204929A (en) * 1978-04-18 1980-05-27 University Patents, Inc. Isoelectric focusing method
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
SE8900586L (sv) 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
US5246707A (en) * 1990-04-26 1993-09-21 Haynes Duncan H Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
US6235313B1 (en) * 1992-04-24 2001-05-22 Brown University Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
US5851994A (en) * 1994-04-28 1998-12-22 La Jolla Cancer Research Foundation Compositions that inhibit wound contraction and methods of using same
US6294202B1 (en) 1994-10-06 2001-09-25 Genzyme Corporation Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
SI9620106B (sl) 1995-08-29 2005-12-31 Fidia Advanced Biopolymers Srl Bioloski materiali za preprecevanje post-kirurskih adhezij, ki se sestojijo iz derivatov hialuronske kisline
DK2111876T3 (da) * 1995-12-18 2011-12-12 Angiodevice Internat Gmbh Tværbundne polymerpræparater og fremgangsmåder til anvendelse deraf
AU7121198A (en) 1997-04-18 1998-11-13 California Institute Of Technology Multifunctional polymeric tissue coatings
SE9702698D0 (sv) 1997-07-14 1997-07-14 Stig Bengmark Compositions for lubricating and separating tissues and biological membranes
JP4241985B2 (ja) * 1998-04-24 2009-03-18 株式会社クラレ 医療用接着材
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP4159682B2 (ja) * 1998-12-22 2008-10-01 株式会社クラレ 止血材
AU784942B2 (en) * 1999-12-15 2006-08-03 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
JP2002136588A (ja) * 2000-11-01 2002-05-14 Kuraray Co Ltd 医療用栓材
US7101947B2 (en) * 2002-06-14 2006-09-05 Florida State University Research Foundation, Inc. Polyelectrolyte complex films for analytical and membrane separation of chiral compounds
EP1633380A4 (de) * 2003-06-19 2010-08-11 Yeda Res & Dev Antimikrobielle und anti-krebs-lipopeptide

Also Published As

Publication number Publication date
EP1701733B1 (de) 2008-04-02
US8461104B2 (en) 2013-06-11
CA2550872A1 (en) 2005-07-14
JP5015604B2 (ja) 2012-08-29
CA2550872C (en) 2016-05-03
JP2007517027A (ja) 2007-06-28
CN1917896A (zh) 2007-02-21
EP1701733A1 (de) 2006-09-20
ES2305897T3 (es) 2008-11-01
US20080019955A1 (en) 2008-01-24
PL1701733T3 (pl) 2008-11-28
DE602004012894T2 (de) 2009-05-14
WO2005063278A1 (en) 2005-07-14
DE602004012894D1 (de) 2008-05-15
US20100260822A1 (en) 2010-10-14
CN1917896B (zh) 2011-07-20

Similar Documents

Publication Publication Date Title
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
TR200100054T2 (tr) Paroksetin metansülfonat
ATE340844T1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
CR10147A (es) "ligandos que tienen especificidad de enlace para vegf y/o egfr y métodos de uso de los mismos"
DE602005018043D1 (de) Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
MEP8209A (en) Modified factor viii
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
CY1111050T1 (el) Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων
ES2534303T3 (es) Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
CR8767A (es) Indazoles sustituidos, composiciones que los contienen, procedimiento de preparacion y su uso
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
DE60108857D1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DE60312211D1 (de) Haarbehandlungsmittel
EE05113B1 (et) Adhesiivssteem, k?vendi kompositsioon, nende kasutamine ja nende pealekandmismeetodid
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
ATE390930T1 (de) Oberflächenschutz von frei liegenden biologischen geweben
TW200509863A (en) Irradiation device for medical use
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties